Cwm, LLC Allakos Inc. Transaction History

Cwm, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 09, 2024	BUY	$1.0 - $1.45 $360 - $522	360 Added 1241.38%	389 $0
Q1 2024 Apr 05, 2024	BUY	$1.02 - $3.23 $29 - $93	29 New	29 $0
Q2 2022 Jul 28, 2022	SELL	$2.6 - $6.14 $75 - $178	-29 Closed	0 $0
Q1 2022 Apr 21, 2022	BUY	$5.08 - $9.81 $121 - $235	24 Added 480.0%	29 $0
Q4 2021 Jan 31, 2022	BUY	$8.55 - $111.89 $42 - $559	5 New	5 $0

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $74.6M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

Stay updated on Cwm, LLC with notifications on news.